NetherlandsOverall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Oncology & Carcinogenesis
SubField 2:
General & Internal Medicine
Rank in SubField 1: 2,326 out of 355,674 Researchers
Data For The Year: 2025
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 55,729 | 57,317 |
| Total Cites | 16,481 | 18,761 |
| H-index | 57 | 65 |
| Hm-index | 20 | 21 |
| Number of Single Authored Papers | 3 | 3 |
| Total Cites to Single Authored Papers | 155 | 160 |
| Number of Single+First Authored Papers | 15 | 15 |
| Total Cites to Single+First Authored Papers | 1,501 | 1,596 |
| Number of Single+First+Last Authored Papers | 37 | 37 |
| Total Cites to Single+First+Last Authored Papers | 3,007 | 3,254 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 13,550 | 14,668 |
| Ratio of Total Citations to Distinct Citing Papers | 1.22 | 1.28 |
| Self-Citation Percentage |
12.15%
|
|
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Oncology & Carcinogenesis
SubField 2:
General & Internal Medicine
Rank in SubField 1: 2,315 out of 334,837 Researchers
Data For The Year: 2024
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 54,036 | 55,531 |
| Total Cites | 15,561 | 17,751 |
| H-index | 56 | 62 |
| Hm-index | 19 | 21 |
| Number of Single Authored Papers | 3 | 3 |
| Total Cites to Single Authored Papers | 152 | 157 |
| Number of Single+First Authored Papers | 15 | 15 |
| Total Cites to Single+First Authored Papers | 1,482 | 1,576 |
| Number of Single+First+Last Authored Papers | 37 | 37 |
| Total Cites to Single+First+Last Authored Papers | 2,911 | 3,155 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 12,818 | 13,880 |
| Ratio of Total Citations to Distinct Citing Papers | 1.21 | 1.28 |
| Self-Citation Percentage |
12.34%
|
|
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Oncology & Carcinogenesis
SubField 2:
General & Internal Medicine
Rank in SubField 1: 2,297 out of 312,644 Researchers
Data For The Year: 2023
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 52,619 | 53,871 |
| Total Cites | 14,755 | 16,801 |
| H-index | 53 | 60 |
| Hm-index | 19 | 20 |
| Number of Single Authored Papers | 2 | 2 |
| Total Cites to Single Authored Papers | 148 | 153 |
| Number of Single+First Authored Papers | 14 | 14 |
| Total Cites to Single+First Authored Papers | 1,461 | 1,553 |
| Number of Single+First+Last Authored Papers | 35 | 35 |
| Total Cites to Single+First+Last Authored Papers | 2,788 | 3,023 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 12,146 | 13,153 |
| Ratio of Total Citations to Distinct Citing Papers | 1.21 | 1.28 |
| Self-Citation Percentage |
12.18%
|
|
SwitzerlandOverall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Oncology & Carcinogenesis
SubField 2:
General & Internal Medicine
Rank in SubField 1: 2,214 out of 293,195 Researchers
Data For The Year: 2022
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 50,560 | 51,733 |
| Total Cites | 13,613 | 15,512 |
| H-index | 51 | 58 |
| Hm-index | 18 | 20 |
| Number of Single Authored Papers | 2 | 2 |
| Total Cites to Single Authored Papers | 142 | 147 |
| Number of Single+First Authored Papers | 14 | 14 |
| Total Cites to Single+First Authored Papers | 1,430 | 1,522 |
| Number of Single+First+Last Authored Papers | 35 | 35 |
| Total Cites to Single+First+Last Authored Papers | 2,641 | 2,872 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 11,248 | 12,189 |
| Ratio of Total Citations to Distinct Citing Papers | 1.21 | 1.27 |
| Self-Citation Percentage |
12.24%
|
|
Trending Researchers
Featured Profiles
Partner with TOPSCINET
Reach science enthusiasts and researchers across the site. Write to business@topscinet.com and our marketing team will send a proposal built around your banner ad goals.